DIASORIN risk profile

48 Elevated one input has moved against it

Measured 21 October 2026 from DIA.MI's filed statements. Recomputed nightly.

48 (Elevated), driven by Competitive position at 62, over 4 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation30NormalStableOne-year price volatility — 38.3%
Operating pressure49ElevatedStableOperating-margin drift — -6.7 percentage points
Cash conversion11ContainedEasingCapital spending against operating cash — 0.18x
Leverage and coverageReads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company.
Competitive position62StretchedStableRevenue-growth gap against peers — -43.5 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for DIASORIN